Extendicare (OTCMKTS:EXETF) Stock Falls 0.9% – What’s Next?

Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) was down 0.9% during mid-day trading on Tuesday. The stock traded as low as $18.87 and last traded at $18.89. 331,330 shares were traded during mid-day trading, an increase of 462% from the average daily volume of 58,940 shares. The stock had previously closed at $19.07.

Wall Street Analyst Weigh In

EXETF has been the subject of several analyst reports. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of Extendicare in a research note on Monday, August 10th. Royal Bank Of Canada restated an “outperform” rating on shares of Extendicare in a research note on Friday, August 14th. Five analysts have rated the stock with a Buy rating, According to MarketBeat, Extendicare presently has a consensus rating of “Buy”.

Check Out Our Latest Stock Report on Extendicare

Extendicare Trading Down 0.9%

The company’s 50-day moving average is $22.49 and its two-hundred day moving average is $22.94.

About Extendicare

(Get Free Report)

Extendicare Inc is a Canadian provider of continuing health-care and senior-living services. The company operates long-term care homes that provide accommodation, nursing care, rehabilitation and other support services for older adults with complex or ongoing care needs.

Through its retirement-living operations, Extendicare also provides independent and assisted-living accommodations, along with dining, wellness and personal-support services. Its ParaMed business delivers home health-care services, including nursing, personal support, therapy and rehabilitation, helping clients remain in their homes and communities.

Extendicare traces its history to 1968 and serves communities across several Canadian provinces, with a significant presence in Ontario.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.